New Medical Technique Can Actually Predict Complications after Surgery for Larynx Cancer
5The patients with the increased risk
Those patients with decreased blood flow possessed higher risk of developing a fistula and those patients with high blood flow had a decreased risk of complications from wounds. Matthew E Spector M.D. assistant professor of otolaryngology who is the senior author of the paper suggested possible interventions. He feels that by cutting a wider margin of tissue to get a cleaner healthier edge or to keep high-risk patients in hospital longer in comparison to the low-risk patients whom they could send home faster.
6Easy to implement
The laser angiography technique could be easy and fairly straight to implement and is being used by various surgeons and those involved in breast reconstruction and several hospitals already possess the infrastructure and equipment to implement it. The technique doesn’t affect or impact patients so much and it can be administered to patients fairly quickly while the patient is still under the affects of anesthesia. Thus any reaction is minimal and negligible.
7Random clinical trials to begin
With the high success rate, researchers are now about to carry out random clinical trials to find out whether cutting back more tissue will lead to low rate of fistula development in the high-risk group. As Spector put it “We need to find an intervention that can lower this risk.”
In another development concerning pharyngeal cancer which usually happens in throat, tonsils and back of tongue, it was found that HPV or human papilloma virus was linked to oropharyngeal cancer and as such was more responsive to treatment. The problem was that 20% of patients did not have successful treatment because of a lack of biomarkers that could relay information that the treatment may fail.
8What scientists found
The clinical cancer research found that in patients where oropharyngeal cancer had recurred had increased levels of antibodies for two proteins E6 and E7. These are usually found also in HPV fueled cancers. The research also found that a blood-based marker could predict when cancer might return.